NTRA has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NTRA has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
As of today (2024-05-16), Natera's current share price is $107.31. Natera's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was $3.37. Natera's Cyclically Adjusted PB Ratio for today is 31.84.
The historical rank and industry rank for Natera's Cyclically Adjusted PB Ratio or its related term are showing as below:
During the past years, Natera's highest Cyclically Adjusted PB Ratio was 31.32. The lowest was 12.97. And the median was 20.65.
The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.
Natera's adjusted book value per share data for the three months ended in Mar. 2024 was $6.497. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $3.37 for the trailing ten years ended in Mar. 2024.
The historical data trend for Natera's Cyclically Adjusted PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Natera Quarterly Data | ||||||||||||||||||||
Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | |
Cyclically Adjusted PB Ratio | Get a 7-Day Free Trial | - | - | 14.98 | 19.07 | 27.15 |
For the Diagnostics & Research subindustry, Natera's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Diagnostics & Research industry and Healthcare sector, Natera's Cyclically Adjusted PB Ratio distribution charts can be found below:
* The bar in red indicates where Natera's Cyclically Adjusted PB Ratio falls into.
Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.
Natera's Cyclically Adjusted PB Ratio for today is calculated as
Cyclically Adjusted PB Ratio | = | Share Price | / | Cyclically Adjusted Book per Share |
= | 107.31 | / | 3.37 | |
= | 31.84 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Natera's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:
For example, Natera's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:
Adj_Book | = | Book Value per Share | / | CPI of Mar. 2024 (Change) | * | Current CPI (Mar. 2024) |
= | 6.497 | / | 129.4194 | * | 129.4194 | |
= | 6.497 |
Current CPI (Mar. 2024) = 129.4194.
Natera Quarterly Data
Book Value per Share | CPI | Adj_Book | |
201406 | 0.000 | 100.560 | 0.000 |
201409 | 0.000 | 100.428 | 0.000 |
201412 | -3.835 | 99.070 | -5.010 |
201503 | 1.354 | 99.621 | 1.759 |
201506 | -4.427 | 100.684 | -5.690 |
201509 | 4.125 | 100.392 | 5.318 |
201512 | 3.670 | 99.792 | 4.760 |
201603 | 3.558 | 100.470 | 4.583 |
201606 | 3.164 | 101.688 | 4.027 |
201609 | 2.679 | 101.861 | 3.404 |
201612 | 2.022 | 101.863 | 2.569 |
201703 | 1.395 | 102.862 | 1.755 |
201706 | 0.957 | 103.349 | 1.198 |
201709 | 0.562 | 104.136 | 0.698 |
201712 | 0.470 | 104.011 | 0.585 |
201803 | -0.071 | 105.290 | -0.087 |
201806 | -0.397 | 106.317 | -0.483 |
201809 | 0.917 | 106.507 | 1.114 |
201812 | 0.518 | 105.998 | 0.632 |
201903 | 0.079 | 107.251 | 0.095 |
201906 | 1.329 | 108.070 | 1.592 |
201909 | 1.195 | 108.329 | 1.428 |
201912 | 3.573 | 108.420 | 4.265 |
202003 | 3.292 | 108.902 | 3.912 |
202006 | 3.817 | 108.767 | 4.542 |
202009 | 6.285 | 109.815 | 7.407 |
202012 | 5.639 | 109.897 | 6.641 |
202103 | 4.260 | 111.754 | 4.933 |
202106 | 3.380 | 114.631 | 3.816 |
202109 | 8.029 | 115.734 | 8.978 |
202112 | 6.867 | 117.630 | 7.555 |
202203 | 5.634 | 121.301 | 6.011 |
202206 | 4.588 | 125.017 | 4.750 |
202209 | 3.717 | 125.227 | 3.841 |
202212 | 6.343 | 125.222 | 6.556 |
202303 | 5.739 | 127.348 | 5.832 |
202306 | 5.227 | 128.729 | 5.255 |
202309 | 6.594 | 129.860 | 6.572 |
202312 | 6.400 | 129.419 | 6.400 |
202403 | 6.497 | 129.419 | 6.497 |
Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.
Thank you for viewing the detailed overview of Natera's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Michael Burkes Brophy | officer: Chief Financial Officer | 201 INDUSTRIAL ROAD, SUITE 410, SAN CARLOS CA 94070 |
Steven Leonard Chapman | officer: Chief Operating Officer | 201 INDUSTRIAL ROAD, SUITE 410, SAN CARLOS CA 94070 |
Daniel Rabinowitz | officer: CHIEF LEGAL OFFICER | C/O NATERA, INC., 13011 MCCALLEN PASS BUILDING A SUITE 100, AUSTIN TX 78753 |
Jonathan Sheena | director, officer: Chief Technology Officer | C/O NATERA, INC., 201 INDUSTRIAL ROAD, SUITE 410, SAN CARLOS CA 94070 |
James Healy | director | 3000 SAND HILL ROAD, 4-250, MENLO PARK CA 94025 |
Gail Boxer Marcus | director | 201 INDUSTRIAL ROAD, SUITE 410, SAN CARLOS CA 94070 |
Rowan E Chapman | director | 201 INDUSTRIAL ROAD, SUITE 410, SAN CARLOS CA 94070 |
Matthew Rabinowitz | director, officer: Chief Executive Officer | C/O NATERA, INC., 201 INDUSTRIAL ROAD, SUITE 410, SAN CARLOS CA 94070 |
Brinkley Ruth Williams | director | C/O TRAVERE THERAPEUTICS, INC., 3611 VALLEY CENTRE DRIVE, SUITE 300, SAN DIEGO CA 92130 |
Robert Alan Schueren | officer: Chief Operating Officer | 7400 PASEO PADRE PARKWAY, FREMONT CA 94555 |
Roelof Botha | director | C/O SEQUOIA CAPITAL, 2800 SAND HILL RD, SUITE 101, MENLO PARK CA 94025 |
Herm Rosenman | officer: Chief Financial Officer | OXFORD IMMUNOTEC GLOBAL PLC, 94C INNOVATION DRIVE, HILTON PARK, SAN DIEGO X0 OX14 4RZ |
Todd C Cozzens | director | ONE FEDERAL STREET, 25TH FLOOR, BOSTON MA 02110 |
Monica Bertagnolli | director | C/O LEAP THERAPEUTICS, INC., 47 THORNDIKE STREET, SUITE B1-1, CAMBRIDGE MA 02141 |
Roy D. Baynes | director | C/O RETROPHIN, INC., 12255 EL CAMINO REAL, SUITE 250, SAN DIEGO CA 92130 |
From GuruFocus
By Business Wire • 10-20-2023
By GuruFocus Research • 12-02-2023
By GuruFocus Research • 01-24-2024
By Business Wire • 12-27-2023
By Business Wire • 01-22-2024
By Business Wire • 10-04-2023
By Business Wire • 10-22-2023
By GuruFocus Research • 12-30-2023
By Business Wire • 10-19-2023